Skip to main content

Closed

DMAC: DiaMedica Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-77.4%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio9.11×

DiaMedica Therapeutics Inc.

DMACNASDAQ Capital Market·USD·Closed

DiaMedica Therapeutics Inc.

DMACNASDAQ·USD·Closed

$6.34

−2.61%

$6.34

−$0.17 (2.61%)

52W Range

36thpctl

Volume

0.45×avg

Mkt Cap

341.62MUSD

P/E

-8.9TTM

Div Yield

–ann

52W Range

36thpctl

Volume

0.45×avg

Market Cap

341.62MUSD

P/E Ratio

-8.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings